Dolutegravir - CAS# 1051375-16-6 Catalog No.:M11383-2 It results in vacuolation of

It results in vacuolation of lysosomes (A) and complete inhibition of the surface expression of Lamp-1

and fixed combination netarsudil-latanoprost

is a pharmaceutical drug substance that is indicated for treatment of chronic myeloid leukemia (CML)

21)/b13-8-

Dolutegravir - CAS# 1051375-16-6 Catalog No.:M11383-2 It results in vacuolation ofDolutegravir, also known as GSK1349572, is a potent inhibitor of HIV integrase with an IC50 value of 2. 7 nM for HIV 1 integrase catalyzed strand transfer in vitro. 1 It inhibits HIV 1 viral replication (EC50 = 0. 51 nM) in peripheral blood mononuclear cells (PBMCs). Dolutegravir (DTG) is an antiretroviral medication used, together with other medication, to treat HIV AIDS. It may also be used, as part of post exposure prophylaxis, to prevent HIV